Document is current
Any future updates will be listed below
-
Authors
Lu, Yalan
Xu, Yanfeng
Zhou, Li
Wang, Siyuan
Han, Yunlin
Wang, Kewei
Qin, Chuan
-
Funding
Funding for this research was provided by:
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2021-I2M-1-034, 2019-I2M-1-004)
Young Elite Scientitsts Sponsorship Program by CAST (2022QNRC001)
the Non-Profit Central Research Institute Fund of the Chinese Academy of Medical Sciences (2023-PT180-01)
- License Information
-
More Information
Article History
Received: 31 August 2024
Accepted: 8 January 2025
First Online: 23 January 2025
Declarations
:
: This was not a clinical trial, so consent to participate was not applicable, nor the declaration of Helsinki for ethical principles for medical research involving human subjects. The mouse study was approved by the Animal Research Ethics Committee of the Institute of Laboratory Animal Science (Approval date: 1th March 2019; Approval number: WKW19001; Project title: Molecular mechanism study of bone marrow mesenchymal stem cell therapy for Alzheimer’s disease), which is carried out according to ARRIVE guidelines ().
: Not applicable.
: The authors declare that they have no competing interests, and we have not use AI-generated work in this manuscript.
